BioCryst Pharmaceuticals ROA 2006-2018 | BCRX

Current and historical return on assets (ROA) values for BioCryst Pharmaceuticals (BCRX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. BioCryst Pharmaceuticals ROA for the three months ending December 31, 2018 was -66.71%.
BioCryst Pharmaceuticals ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-12-31 $-0.10B $0.15B -66.56%
2018-09-30 $-0.09B $0.17B -58.93%
2018-06-30 $-0.08B $0.14B -47.81%
2018-03-31 $-0.08B $0.16B -48.90%
2017-12-31 $-0.07B $0.18B -43.07%
2017-09-30 $-0.05B $0.19B -38.86%
2017-06-30 $-0.05B $0.11B -45.07%
2017-03-31 $-0.05B $0.13B -47.72%
2016-12-31 $-0.06B $0.09B -61.04%
2016-09-30 $-0.07B $0.09B -69.17%
2016-06-30 $-0.07B $0.08B -64.57%
2016-03-31 $-0.05B $0.10B -39.69%
2015-12-31 $-0.04B $0.12B -31.79%
2015-09-30 $-0.04B $0.14B -26.62%
2015-06-30 $-0.03B $0.15B -22.38%
2015-03-31 $-0.05B $0.13B -37.36%
2014-12-31 $-0.05B $0.14B -40.09%
2014-09-30 $-0.04B $0.14B -42.05%
2014-06-30 $-0.04B $0.14B -52.96%
2014-03-31 $-0.04B $0.04B -75.68%
2013-12-31 $-0.03B $0.05B -63.49%
2013-09-30 $-0.04B $0.05B -73.10%
2013-06-30 $-0.04B $0.04B -73.08%
2013-03-31 $-0.04B $0.05B -62.30%
2012-12-31 $-0.04B $0.06B -56.32%
2012-09-30 $-0.04B $0.06B -54.30%
2012-06-30 $-0.05B $0.08B -54.38%
2012-03-31 $-0.05B $0.08B -53.99%
2011-12-31 $-0.06B $0.08B -55.17%
2011-09-30 $-0.05B $0.09B -48.96%
2011-06-30 $-0.05B $0.11B -44.35%
2011-03-31 $-0.04B $0.12B -38.34%
2010-12-31 $-0.03B $0.11B -29.50%
2010-09-30 $-0.01B $0.11B -7.29%
2010-06-30 $-0.01B $0.12B -8.11%
2010-03-31 $-0.01B $0.13B -8.14%
2009-12-31 $-0.01B $0.14B -16.42%
2009-09-30 $-0.02B $0.06B -26.76%
2009-06-30 $-0.02B $0.07B -21.12%
2009-03-31 $-0.02B $0.07B -23.01%
2008-12-31 $-0.03B $0.09B -23.75%
2008-09-30 $-0.04B $0.10B -30.90%
2008-06-30 $-0.04B $0.11B -29.94%
2008-03-31 $-0.03B $0.13B -26.88%
2007-12-31 $-0.03B $0.14B -26.98%
2007-09-30 $-0.04B $0.14B -41.69%
2007-06-30 $-0.04B $0.08B -57.14%
2007-03-31 $-0.05B $0.07B -58.44%
2006-12-31 $-0.04B $0.07B -51.46%
2006-09-30 $-0.04B $0.08B -43.97%
2006-06-30 $-0.03B $0.09B -39.88%
2006-03-31 $-0.03B $0.10B -41.13%
2005-12-31 $-0.03B $0.10B -47.16%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.842B $0.021B
BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $47.159B 31.37
Takeda Pharmaceutical (TAK) Japan $33.481B 12.39
Grifols (GRFS) Spain $13.146B 15.93
Ionis Pharmaceuticals (IONS) United States $11.101B 34.42
Neurocrine Biosciences (NBIX) United States $7.704B 499.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.621B 10.91
Sage Therapeutics (SAGE) United States $7.180B 0.00
Tilray (TLRY) United States $6.589B 0.00
Catalent (CTLT) United States $6.182B 25.88
Nektar Therapeutics (NKTR) United States $5.678B 9.06
United Therapeutics (UTHR) United States $5.301B 9.01
FibroGen (FGEN) United States $4.713B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.271B 22.70
Taro Pharmaceutical Industries (TARO) Israel $4.241B 13.65
Zogenix (ZGNX) United States $2.213B 0.00
Portola Pharmaceuticals (PTLA) United States $2.200B 0.00
PTC Therapeutics (PTCT) United States $2.197B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.160B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.117B 0.00
Aerie Pharmaceuticals (AERI) United States $2.085B 0.00
USANA Health Sciences (USNA) United States $2.034B 17.07
Endo (ENDP) Ireland $1.959B 3.02
Heron Therapeutics (HRTX) United States $1.931B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.887B 23.51
Xencor (XNCR) United States $1.819B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.747B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.637B 141.79
Corcept Therapeutics (CORT) United States $1.369B 19.88
Theravance Biopharma (TBPH) Cayman Islands $1.345B 0.00
TherapeuticsMD (TXMD) United States $1.331B 0.00
Esperion Therapeutics (ESPR) United States $1.158B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.112B 0.00
Tricida (TCDA) United States $1.072B 0.00
Radius Health (RDUS) United States $0.843B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.624B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.604B 0.00
Collegium Pharmaceutical (COLL) United States $0.587B 0.00
Dermira (DERM) United States $0.577B 0.00
Odonate Therapeutics (ODT) United States $0.571B 0.00
Forty Seven (FTSV) United States $0.566B 0.00
ChemoCentryx (CCXI) United States $0.557B 0.00
GlycoMimetics (GLYC) United States $0.556B 0.00
ArQule (ARQL) United States $0.546B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.494B 29.15
Akebia Therapeutics (AKBA) United States $0.492B 0.00
Siga Technologies (SIGA) United States $0.484B 0.00
KalVista Pharmaceuticals (KALV) United States $0.477B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.468B 0.00
Flexion Therapeutics (FLXN) United States $0.456B 0.00
Translate Bio (TBIO) United States $0.433B 0.00
TCR2 THERAPTCS (TCRR) United States $0.431B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.430B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.413B 0.00
Concert Pharmaceuticals (CNCE) United States $0.403B 0.00
OptiNose (OPTN) United States $0.388B 0.00
Aptorum Group (APM) China $0.382B 0.00
ImmunoGen (IMGN) United States $0.368B 0.00
Minerva Neurosciences (NERV) United States $0.330B 0.00
Karyopharm Therapeutics (KPTI) United States $0.329B 0.00
CASI Pharmaceuticals (CASI) United States $0.316B 0.00
Lannett Co Inc (LCI) United States $0.312B 2.89
Verrica Pharmaceuticals (VRCA) United States $0.310B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.307B 11.36
HARPOON THERAPT (HARP) United States $0.285B 0.00
Mast Therapeutics (SVRA) United States $0.283B 0.00
Immune Design (IMDZ) United States $0.282B 0.00
Xeris Pharmaceuticals (XERS) United States $0.271B 0.00
Affimed (AFMD) Germany $0.271B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.266B 0.00
Aclaris Therapeutics (ACRS) United States $0.265B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.264B 0.00
Dova Pharmaceuticals (DOVA) United States $0.264B 0.00
Majesco Entertainment (PTE) United States $0.262B 0.00
Calithera Biosciences (CALA) United States $0.259B 0.00
Opexa Therapeutics (ACER) United States $0.240B 0.00
Tyme Technologies (TYME) United States $0.236B 0.00
ElectroCore (ECOR) United States $0.233B 0.00
Galectin Therapeutics (GALT) United States $0.227B 0.00
Jounce Therapeutics (JNCE) United States $0.223B 0.00
MEI Pharma (MEIP) United States $0.221B 0.00
Aldeyra Therapeutics (ALDX) United States $0.214B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.210B 0.00
Molecular Templates (MTEM) United States $0.208B 0.00
Ardelyx (ARDX) United States $0.207B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.205B 0.00
IMV INC (IMV) Canada $0.205B 0.00
Recro Pharma (REPH) United States $0.200B 0.00
Rafael Holdings (RFL) United States $0.199B 0.00
Aratana Therapeutics (PETX) United States $0.197B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.193B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.192B 0.00
Redhill Biopharma (RDHL) Israel $0.189B 0.00
Nature's Sunshine Products (NATR) United States $0.186B 193.00
Galmed Pharmaceuticals (GLMD) Israel $0.183B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.181B 0.00
Ocular Therapeutix (OCUL) United States $0.178B 0.00
Aquestive Therapeutics (AQST) United States $0.174B 0.00
Neon Therapeutics (NTGN) United States $0.160B 0.00
Neos Therapeutics (NEOS) United States $0.156B 0.00
AgeX Therapeutics (AGE) United States $0.145B 0.00
MediWound (MDWD) Israel $0.142B 0.00
ProNAi Therapeutics (SRRA) Canada $0.141B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.139B 0.00
China SXT Pharmaceuticals (SXTC) China $0.139B 0.00
Cardiome Pharma (CORV) Canada $0.134B 0.00
Champions Oncology (CSBR) United States $0.124B 0.00
DURECT (DRRX) United States $0.122B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.120B 0.00
Zafgen (ZFGN) United States $0.111B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.110B 0.00
Adherex Technologies (FENC) United States $0.109B 0.00
Infinity Pharmaceuticals (INFI) United States $0.099B 0.00
Nivalis Therapeutics (ALPN) United States $0.097B 0.00
Iterum Therapeutics (ITRM) Ireland $0.095B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.091B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Otonomy (OTIC) United States $0.090B 0.00
Avenue Therapeutics (ATXI) United States $0.090B 0.00
SCYNEXIS (SCYX) United States $0.084B 0.00
Natural Alternatives (NAII) United States $0.084B 8.16
Genocea Biosciences (GNCA) United States $0.081B 0.00
India Globalization Capital (IGC) United States $0.075B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.073B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.072B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.069B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.066B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.060B 0.00
CTI BioPharma (CTIC) United States $0.059B 0.00
Forward Pharma (FWP) Denmark $0.057B 0.00
KemPharm (KMPH) United States $0.055B 0.00
Bio-Path Holdings (BPTH) United States $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00
Lipocine (LPCN) United States $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Melinta Therapeutics (MLNT) United States $0.049B 0.00
BioLineRx (BLRX) Israel $0.047B 0.00
Capnia (SLNO) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.043B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
ProPhase Labs (PRPH) United States $0.038B 0.00
ContraFect (CFRX) United States $0.037B 0.00
NOVAN INC (NOVN) United States $0.036B 0.00
Achaogen (AKAO) United States $0.034B 0.00
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
Shineco (TYHT) China $0.028B 4.77
PharmAthene (ALT) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.027B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.026B 0.00
IsoRay (ISR) United States $0.026B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
Biomerica (BMRA) United States $0.024B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.023B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.022B 0.00
Pain Therapeutics (PTIE) United States $0.022B 0.00
Achieve Life Sciences (ACHV) United States $0.021B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
NanoViricides (NNVC) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.006B 0.00
Intellipharmaceutics (IPCI) Canada $0.005B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00